A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.

about

A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples.

Item

http://www.wikidata.org/entity/Q52631121

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A novel high-throughput immuno ...... strophy muscle biopsy samples.

@en

A novel high-throughput immuno ...... strophy muscle biopsy samples.

@nl

type

Item

label

A novel high-throughput immuno ...... strophy muscle biopsy samples.

@en

A novel high-throughput immuno ...... strophy muscle biopsy samples.

@nl

prefLabel

A novel high-throughput immuno ...... strophy muscle biopsy samples.

@en

A novel high-throughput immuno ...... strophy muscle biopsy samples.

@nl

P1476

A novel high-throughput immuno ...... strophy muscle biopsy samples.

@en

P2093

Caroline Sewry

http://www.w3.org/2001/XMLSchema#string

Darren Chambers

http://www.w3.org/2001/XMLSchema#string

Deborah Eastwood

http://www.w3.org/2001/XMLSchema#string

Francesco Muntoni

http://www.w3.org/2001/XMLSchema#string

Jennifer E Morgan

http://www.w3.org/2001/XMLSchema#string

Lucy Feng

http://www.w3.org/2001/XMLSchema#string

Rahul Phadke

http://www.w3.org/2001/XMLSchema#string

Silvia Torelli

http://www.w3.org/2001/XMLSchema#string

P2860

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy

Dystrophin and mutations: one gene, several proteins, multiple phenotypes.

Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.

Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.

Dystrophin quantification: Biological and translational research implications.

Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.

How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse

Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).

P304

e0194540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0194540

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Valentina Sardone

Matthew Ellis

P577

2018-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29579078

http://www.w3.org/2001/XMLSchema#string

P921

immunofluorescence microscopy

P932

5868811

http://www.w3.org/2001/XMLSchema#string